A study by Rastogi et al. (2007) reported that anti-GLUT1 antibodies could arrest cell growth accompanied by induction of apoptosis in cell lines derived from breast and non-small cell lung cancer (NSCLC). Here, SLC2A1 is linked to non-small cell lung carcinoma.